Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis

NCT00579956 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT00579956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00579956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Unknown status
Start date
December 31, 2007
Completion date
September 30, 2010
Enrollment
750 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melioidosis